872
Views
20
CrossRef citations to date
0
Altmetric
Reports

MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells

, , , , , , , , & show all
Pages 1954-1964 | Received 12 Jun 2017, Accepted 07 Aug 2017, Published online: 12 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shokoofeh Ghaemi, Zahra Fekrirad, Nina Zamani, Rana Rahmani & Ehsan Arefian. (2022) Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform. Journal of Drug Targeting 30:6, pages 589-602.
Read now

Articles from other publishers (19)

Ping Zhang, Zilin Wang, Weicheng Sun, Jinsheng Xu, Weihan Zhang, Kun Wu, Leon Wong & Li Li. (2023) RDRGSE: A Framework for Noncoding RNA-Drug Resistance Discovery by Incorporating Graph Skeleton Extraction and Attentional Feature Fusion. ACS Omega 8:30, pages 27386-27397.
Crossref
Jin Gu Cho, Sung-wook Kim, Aram Lee, Ha-neul Jeong, Eunsik Yun, Jihea Choi, Su Jin Jeong, Woochul Chang, Sumin Oh, Kyung Hyun Yoo, Jung Bok Lee, Sukjoon Yoon, Myeong-Sok Lee, Jong Hoon Park, Min Hyung Jung, So-Woon Kim, Ki Hyung Kim, Dong Soo Suh, Kyung Un Choi, Jungmin Choi, Jongmin Kim & Byung Su Kwon. (2022) MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer. Molecular Therapy - Nucleic Acids 29, pages 803-822.
Crossref
Guna He, Xiaomei Liu & Lingyu Liu. (2022) microRNA-26b inhibits growth and cellular invasion of ovarian cancer cells by targeting estrogen receptor α. 3 Biotech 12:8.
Crossref
Xiaodong Li, Yichang Wang, Wei Wu, Jianyang Xiang, Maode Wang & Hai Yu. (2022) A novel DNA damage and repair‐related gene signature to improve predictive capacity of overall survival for patients with gliomas . Journal of Cellular and Molecular Medicine 26:13, pages 3736-3750.
Crossref
Parvaneh Mahinfar, Behnaz Mansoori, Davoud Rostamzadeh, Behzad Baradaran, William C. Cho & Behzad Mansoori. (2022) The Role of microRNAs in Multidrug Resistance of Glioblastoma. Cancers 14:13, pages 3217.
Crossref
Huali Fan, Xiaofang Xie, Xi Kuang, Junrong Du & Fu Peng. (2022) MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine. The American Journal of Chinese Medicine 50:07, pages 1799-1825.
Crossref
Ke Gao, Tuo Wang, Yuan Qiao & Bo Cui. (2021) miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma. Acta Biochimica et Biophysica Sinica 53:8, pages 979-987.
Crossref
Lixia Wang, Chuanlai Yang, Man Chu, Zhi-wei Wang & Boxin Xue. (2021) Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Letters 500, pages 172-181.
Crossref
Guangtao Pan, Yuhan Liu, Luorui Shang, Fangyuan Zhou & Shenglan Yang. (2021) EMT‐associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Communications 41:3, pages 199-217.
Crossref
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, Riccardo Leardi, Emanuele Farinini, Gilberto Fronza, Paola Menichini, Paola Monti, Lorenzo Monteleone, Giulia Elda Valenti, Andrea Speciale, Patrizia Perri, Francesca Madia, Alberto Izzotti & Cinzia Domenicotti. (2021) Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma. Journal of Personalized Medicine 11:2, pages 107.
Crossref
Saeedeh Ghiasvand, Mohammad Amin Javidi, Ali Mohammadian, Seyed Ahmad Mousavi, Fatemeh Shahriari & Firoozeh Alavian. (2021) Transcriptome analysis evinces anti-neoplastic mechanisms of hypericin: A study on U87 glioblastoma cell line. Life Sciences 266, pages 118874.
Crossref
Fengsheng Dai, Li Dai, Xiwang Zheng, Yujia Guo, Yuliang Zhang, Min Niu, Yan Lu, Huizheng Li, Rui Hou, Yu Zhang, Shuxin Wen, Wanglai Hu, Changming An, Yongyan Wu & Wei Gao. (2020) Non-coding RNAs in drug resistance of head and neck cancers: A review. Biomedicine & Pharmacotherapy 127, pages 110231.
Crossref
Yanling Liu, Zijun Zhou, Jingzhe Yan, Xuefeng Wu & Guiying Xu. (2020) Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells. BioMed Research International 2020, pages 1-10.
Crossref
Barbara Marengo, Alessandra Pulliero, Alberto Izzotti & Cinzia Domenicotti. (2020) miRNA Regulation of Glutathione Homeostasis in Cancer Initiation, Progression and Therapy Resistance. MicroRNA 9:3, pages 187-197.
Crossref
Feng-Mei Pang, Han Yan, Jun-Luan Mo, Dan Li, Yi Chen, Longbo Zhang, Zhao-Qian Liu, Hong-Hao Zhou, Jun Wu & Xi Li. (2020) Integrative analyses identify a DNA damage repair gene signature for prognosis prediction in lower grade gliomas. Future Oncology 16:8, pages 367-382.
Crossref
Sheng Xin, Kai Huang & Xin-Gen Zhu. (2019) Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation. Pathology - Research and Practice 215:9, pages 152539.
Crossref
Wenjia Ma, Yan Cui, Min Liu, Zhigang Tan & Yugang Jiang. (2019) Downregulation of miR-125b promotes resistance of glioma cells to TRAIL through overexpression of Tafazzin which is a mitochondrial protein. Aging 11:9, pages 2670-2680.
Crossref
Cong Zhang, Xiuqin Yang, Chen Fu & Xin Liu. (2018) Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway. Gene 672, pages 172-179.
Crossref
Nan Wang, Yuanting Gu, Lin Li, Fang Wang, Pengwei Lv, Youyi Xiong & Xinguang Qiu. (2018) Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. Archives of Biochemistry and Biophysics 653, pages 63-70.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.